Published in Drug Week, May 13th, 2005
Immtech holds an exclusive worldwide license to commercialize this patent, issued on March 15, 2005, to The University of North Carolina at Chapel Hill (UNC) and Georgia State University (GSU) in Atlanta, Georgia. This patent adds to the potential use of Immtech's compounds as small molecule drugs that can control gene expression selectively and provide treatments for microbial infections,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.